CHIPS and Science Act (Market Impact)
The CHIPS and Science Act of 2022 is federal legislation that provided approximately $52 billion in direct subsidies and a 25% investment tax credit for domestic semiconductor manufacturing, alongside $200 billion in science and technology research funding, aimed at rebuilding US chip production capacity and reducing dependence on Asian supply chains.
Signed into law in August 2022, the CHIPS and Science Act addressed a strategic vulnerability that the COVID-19 pandemic had made unmistakably clear: US production of advanced semiconductors — the foundational components of virtually all modern technology — had declined dramatically over decades of offshoring, leaving the economy dependent on a geographically concentrated supply chain centered on Taiwan.
The CHIPS for America Fund provided $39 billion for semiconductor manufacturing incentives distributed by the Department of Commerce. Companies constructing or expanding chip fabrication facilities in the United States can apply for grants, loans, and loan guarantees. The program prioritized leading-edge logic chips (the most advanced and strategically sensitive category) but also funded mature-node chips critical for automotive, defense, and industrial applications. Major recipients of grant commitments announced in 2023-2024 included TSMC (building a $65 billion fab complex in Arizona), Intel (expanding US fabrication), Samsung (Texas facility), and Micron (memory chips).
The 25% advanced manufacturing investment credit (AMIC) for semiconductor equipment and construction provides a dollar-for-dollar offset against federal tax liability for qualifying capital expenditures. For capital-intensive fab construction costing tens of billions of dollars, this credit effectively reduces the after-tax cost of domestic investment substantially. The AMIC is available without application or review — unlike the grant program — making it a reliable planning input for companies evaluating facility decisions.
For equity markets, CHIPS Act passage reshaped valuation and capital allocation across the semiconductor supply chain. Equipment manufacturers, materials suppliers, and construction companies serving the fab buildout benefited from a multi-year, government-supported investment cycle. The legislation also contained guardrails — recipients of CHIPS funding are restricted from expanding leading-edge production in countries of concern (principally China) for ten years, structuring an implicit separation between US-aligned and China-aligned fab capacity.
The science funding provisions ($200 billion over ten years) directed the National Science Foundation, Department of Energy, and other agencies to increase research in quantum computing, artificial intelligence, advanced manufacturing, and biotechnology.